Bondronat, also known by its generic name ibandronate sodium, is a prescription medication that belongs to a class of drugs known as bisphosphonates. It is primarily used in the treatment and prevention of osteoporosis in postmenopausal women, aiming to strengthen bones by increasing bone density and reducing the likelihood of fractures. Bondronat works by inhibiting the activity of osteoclasts, the cells responsible for bone resorption, thereby slowing down the process of bone loss. It is available in both oral tablet form and as an intravenous injection, allowing for flexibility in administration based on the patient's needs and medical advice. By helping to maintain or increase bone mass, Bondronat plays a crucial role in managing osteoporosis and improving the quality of life for those affected by this condition.